| Serial Number | 90459471 |
| Word Mark | EVERY IMMUNE SYSTEM HAS A STORY TO TELL. THE KEY IS KNOWING HOW TO LISTEN. |
| Filing Date | Monday, January 11, 2021 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, July 9, 2024 |
| Registration Number | 7443900 |
| Registration Date | Tuesday, July 9, 2024 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, September 7, 2021 |
| Goods and Services | Providing medical diagnostic assays and diagnostic and prognostic testing for medical research purposes of residual disease, and the analysis, evaluation, and reporting of those test results to help healthcare professionals for research purposes; development of new technology for others in the field of biotechnology; DNA analysis services for scientific research purposes; genetic testing for scientific research purposes; genome amplification; genotyping services for research or analysis purposes; laboratory research in the field of immune sequencing; medical and scientific research in the field of cancer treatment and diagnosis; medical and scientific research in the field of immune sequencing; providing laboratory research services in the field of gene expression, namely, cancer biology; providing medical and scientific research information in the field of clinical trials; providing medical and scientific research information in the fields of pharmaceuticals and genetics; research and development in the pharmaceutical and biotechnology fields; research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; scientific research in the field of genetics and genetic engineering; DNA screening for scientific research purposes; medical research; consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; custom design and development of chemical reagents and biochemical assays; development of new technology for others in the field of immunotherapy; laboratory research in the field of immunotherapy, oncology, hematology, auto-immune disorders, and infectious diseases; medical and scientific research in the field of immunotherapy; medical laboratory services |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Sunday, April 11, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | Friday, July 31, 2020 |
| First Use In Commerce Date | Friday, July 31, 2020 |
| Party Name | Adaptive Biotechnologies Corp. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Seattle, WA 98102 |
| Party Name | Adaptive Biotechnologies Corp. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Seattle, WA 98102 |
| Party Name | Adaptive Biotechnologies Corp. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Seattle, WA 98102 |
| Event Date | Event Description |
| Thursday, January 14, 2021 | NEW APPLICATION ENTERED |
| Sunday, April 11, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, July 20, 2021 | ASSIGNED TO EXAMINER |
| Wednesday, July 28, 2021 | EXAMINERS AMENDMENT -WRITTEN |
| Wednesday, July 28, 2021 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, July 28, 2021 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, July 28, 2021 | EXAMINER'S AMENDMENT ENTERED |
| Monday, August 2, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, September 7, 2021 | PUBLISHED FOR OPPOSITION |
| Tuesday, September 7, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Wednesday, August 18, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, November 2, 2021 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Monday, May 2, 2022 | SOU TEAS EXTENSION RECEIVED |
| Monday, May 2, 2022 | SOU EXTENSION 1 FILED |
| Monday, May 2, 2022 | SOU EXTENSION 1 GRANTED |
| Wednesday, May 4, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, November 2, 2022 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, November 2, 2022 | SOU EXTENSION 2 FILED |
| Wednesday, November 2, 2022 | SOU EXTENSION 2 GRANTED |
| Friday, November 4, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, May 1, 2023 | SOU EXTENSION 3 FILED |
| Monday, May 1, 2023 | SOU EXTENSION 3 GRANTED |
| Monday, May 1, 2023 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, May 3, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, November 2, 2023 | SOU TEAS EXTENSION RECEIVED |
| Thursday, November 2, 2023 | SOU EXTENSION 4 FILED |
| Thursday, November 2, 2023 | SOU EXTENSION 4 GRANTED |
| Saturday, November 4, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, April 30, 2024 | TEAS STATEMENT OF USE RECEIVED |
| Tuesday, May 28, 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Thursday, May 30, 2024 | STATEMENT OF USE PROCESSING COMPLETE |
| Friday, May 31, 2024 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Friday, May 31, 2024 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Tuesday, July 9, 2024 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, July 9, 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |